<div id="subtitle">Keryx Biopharma, FDA agree on design of late-stage trial for drug against colorectal cancer</div><div><p>Keryx Biopharmaceuticals Inc. said Wednesday it reached an agreement with regulators on the design of a late-stage study of its cancer drug candidate perifosine.</p><p>The agreement ...

<div id="subtitle">Aeterna Zentaris partner reaches agreement with FDA on design of phase 3 trial for perifosine</div><div><p>In breaking news Monday, Quebec-based biopharmaceutical company Aeterna Zentaris (TSX: T.AEZ, Stock Forum), announced that its partner Keryx Biopharmaceuticals (NASDAQ: KERX, Stock Forum) has reached an agreement with the ...